Listed

Evolent Health, Inc.

EVHNYSECIK 1628908IndustrialsFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$652.5m, Q2 FY2026
Operating income−$9.6m, Q2 FY2026
Net income−$28.4m, Q2 FY2026
Evolent Health, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m511Revenue, Q3 FY2023, three months to 2023-09-30$511.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure556Revenue, Q4 FY2023, three months to 2023-12-31$556.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure640Revenue, Q1 FY2024, three months to 2024-03-31$639.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure647Revenue, Q2 FY2024, three months to 2024-06-30$647.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure621Revenue, Q3 FY2024, three months to 2024-09-30$621.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure647Revenue, Q4 FY2024, three months to 2024-12-31$646.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure484Revenue, Q1 FY2025, three months to 2025-03-31$483.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure444Revenue, Q2 FY2025, three months to 2025-06-30$444.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure480Revenue, Q3 FY2025, three months to 2025-09-30$479.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure469Revenue, Q4 FY2025, three months to 2025-12-31$468.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure496Revenue, Q1 FY2026, three months to 2026-03-31$496.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure653Revenue, Q2 FY2026, three months to 2026-06-30$652.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Cost of revenue$m387Cost of revenue, Q3 FY2023, three months to 2023-09-30$386.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure454Cost of revenue, Q4 FY2023, three months to 2023-12-31$454.4m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure536Cost of revenue, Q1 FY2024, three months to 2024-03-31$535.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure540Cost of revenue, Q2 FY2024, three months to 2024-06-30$540.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure541Cost of revenue, Q3 FY2024, three months to 2024-09-30$540.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure571Cost of revenue, Q4 FY2024, three months to 2024-12-31$570.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure381Cost of revenue, Q1 FY2025, three months to 2025-03-31$381.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure344Cost of revenue, Q2 FY2025, three months to 2025-06-30$343.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure380Cost of revenue, Q3 FY2025, three months to 2025-09-30$379.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure371Cost of revenue, Q4 FY2025, three months to 2025-12-31$371.5m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure412Cost of revenue, Q1 FY2026, three months to 2026-03-31$412.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure572Cost of revenue, Q2 FY2026, three months to 2026-06-30$571.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m96.6Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$96.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure81.4Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$81.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure79.1Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$79.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure69.2Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$69.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure67.1Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$67.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure47.7Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$47.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure78.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$78.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure75.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$75.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure77.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$77.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure72.7Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$72.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure72.8Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$72.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure68.8Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$68.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Operating income$m(17.9)Operating income, Q3 FY2023, three months to 2023-09-30−$17.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure(21.4)Operating income, Q4 FY2023, three months to 2023-12-31−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(13.4)Operating income, Q1 FY2024, three months to 2024-03-31−$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure7.8Operating income, Q2 FY2024, three months to 2024-06-30$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure(16.3)Operating income, Q3 FY2024, three months to 2024-09-30−$16.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure(18.6)Operating income, Q4 FY2024, three months to 2024-12-31−$18.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(1.6)Operating income, Q1 FY2025, three months to 2025-03-31−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(1.2)Operating income, Q2 FY2025, three months to 2025-06-30−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure0.9Operating income, Q3 FY2025, three months to 2025-09-30$886.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure(408)Operating income, Q4 FY2025, three months to 2025-12-31−$408.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Operating income, Q1 FY2026, three months to 2026-03-31−$10.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(9.6)Operating income, Q2 FY2026, three months to 2026-06-30−$9.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Interest expense$m14.6Interest expense, Q3 FY2023, three months to 2023-09-30$14.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-02, accession 0001628908-23-000165.Report this figure12.2Interest expense, Q4 FY2023, three months to 2023-12-31$12.2m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-23, accession 0001628908-24-000017. Derived: 12-month figure less the 9-month figure.Report this figure6.0Interest expense, Q1 FY2024, three months to 2024-03-31$6.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-10, accession 0001628908-24-000053.Report this figure6.0Interest expense, Q2 FY2024, three months to 2024-06-30$6.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure6.0Interest expense, Q3 FY2024, three months to 2024-09-30$6.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure6.7Interest expense, Q4 FY2024, three months to 2024-12-31$6.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure10.4Interest expense, Q1 FY2025, three months to 2025-03-31$10.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure11.6Interest expense, Q2 FY2025, three months to 2025-06-30$11.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure16.5Interest expense, Q3 FY2025, three months to 2025-09-30$16.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure19.0Interest expense, Q4 FY2025, three months to 2025-12-31$19.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure16.9Interest expense, Q1 FY2026, three months to 2026-03-31$16.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure16.9Interest expense, Q2 FY2026, three months to 2026-06-30$16.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Income tax$m(5.6)Income tax, Q3 FY2023, three months to 2023-09-30−$5.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure(14.7)Income tax, Q4 FY2023, three months to 2023-12-31−$14.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2024, three months to 2024-03-31$565.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure(0.2)Income tax, Q2 FY2024, three months to 2024-06-30−$238.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure(0.6)Income tax, Q3 FY2024, three months to 2024-09-30−$619.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure(1.1)Income tax, Q4 FY2024, three months to 2024-12-31−$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure1.5Income tax, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(0.8)Income tax, Q2 FY2025, three months to 2025-06-30−$825.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure0.9Income tax, Q3 FY2025, three months to 2025-09-30$906.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure(1.7)Income tax, Q4 FY2025, three months to 2025-12-31−$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure0.9Income tax, Q1 FY2026, three months to 2026-03-31$910.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure2.7Income tax, Q2 FY2026, three months to 2026-06-30$2.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Net income$m(25.3)Net income, Q3 FY2023, three months to 2023-09-30−$25.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure(33.4)Net income, Q4 FY2023, three months to 2023-12-31−$33.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure(17.3)Net income, Q1 FY2024, three months to 2024-03-31−$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure1.6Net income, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(23.1)Net income, Q3 FY2024, three months to 2024-09-30−$23.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(22.8)Net income, Q4 FY2024, three months to 2024-12-31−$22.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(64.6)Net income, Q1 FY2025, three months to 2025-03-31−$64.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(19.9)Net income, Q2 FY2025, three months to 2025-06-30−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure(20.9)Net income, Q3 FY2025, three months to 2025-09-30−$20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(429)Net income, Q4 FY2025, three months to 2025-12-31−$429.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(26.6)Net income, Q1 FY2026, three months to 2026-03-31−$26.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(28.4)Net income, Q2 FY2026, three months to 2026-06-30−$28.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Diluted EPS$ per share(0.30)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure(0.36)Diluted EPS, Q4 FY2023, three months to 2023-12-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure(0.22)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.06)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.27)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.27)Diluted EPS, Q4 FY2024, three months to 2024-12-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.63)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(0.44)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure(0.24)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(3.84)Diluted EPS, Q4 FY2025, three months to 2025-12-31−$3.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.24)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(0.25)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Basic EPS$ per share(0.30)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure(0.36)Basic EPS, Q4 FY2023, three months to 2023-12-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure(0.22)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.06)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.27)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.27)Basic EPS, Q4 FY2024, three months to 2024-12-31−$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.63)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(0.44)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure(0.24)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(3.84)Basic EPS, Q4 FY2025, three months to 2025-12-31−$3.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure(0.24)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(0.25)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure

Balance sheet

Cash and equivalents$115.7m, Q2 FY2026
Long-term debt$966.5m, Q2 FY2026
Shareholders' equity$383.2m, Q2 FY2026
Evolent Health, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m185Cash and equivalents, Q3 FY2023, at 2023-09-30$184.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure193Cash and equivalents, FY2023, at 2023-12-31$192.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure165Cash and equivalents, Q1 FY2024, at 2024-03-31$165.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure101Cash and equivalents, Q2 FY2024, at 2024-06-30$101.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure96.6Cash and equivalents, Q3 FY2024, at 2024-09-30$96.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure104Cash and equivalents, FY2024, at 2024-12-31$104.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure247Cash and equivalents, Q1 FY2025, at 2025-03-31$246.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure151Cash and equivalents, Q2 FY2025, at 2025-06-30$151.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure117Cash and equivalents, Q3 FY2025, at 2025-09-30$116.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure152Cash and equivalents, FY2025, at 2025-12-31$151.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure142Cash and equivalents, Q1 FY2026, at 2026-03-31$142.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure116Cash and equivalents, Q2 FY2026, at 2026-06-30$115.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Current assets$m639Current assets, Q3 FY2023, at 2023-09-30$638.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0001628908-23-000165.Report this figure684Current assets, FY2023, at 2023-12-31$683.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure669Current assets, Q1 FY2024, at 2024-03-31$669.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-10, accession 0001628908-24-000053.Report this figure521Current assets, Q2 FY2024, at 2024-06-30$521.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001628908-24-000090.Report this figure544Current assets, Q3 FY2024, at 2024-09-30$544.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure607Current assets, FY2024, at 2024-12-31$607.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure728Current assets, Q1 FY2025, at 2025-03-31$727.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure562Current assets, Q2 FY2025, at 2025-06-30$562.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure570Current assets, Q3 FY2025, at 2025-09-30$570.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure506Current assets, FY2025, at 2025-12-31$506.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure502Current assets, Q1 FY2026, at 2026-03-31$502.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure611Current assets, Q2 FY2026, at 2026-06-30$610.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Total assets$m2,670Total assets, Q3 FY2023, at 2023-09-30$2.67bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0001628908-23-000165.Report this figure2,680Total assets, FY2023, at 2023-12-31$2.68bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure2,644Total assets, Q1 FY2024, at 2024-03-31$2.64bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-10, accession 0001628908-24-000053.Report this figure2,475Total assets, Q2 FY2024, at 2024-06-30$2.48bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001628908-24-000090.Report this figure2,502Total assets, Q3 FY2024, at 2024-09-30$2.50bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure2,544Total assets, FY2024, at 2024-12-31$2.54bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure2,653Total assets, Q1 FY2025, at 2025-03-31$2.65bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure2,462Total assets, Q2 FY2025, at 2025-06-30$2.46bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure2,453Total assets, Q3 FY2025, at 2025-09-30$2.45bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure1,899Total assets, FY2025, at 2025-12-31$1.90bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure1,879Total assets, Q1 FY2026, at 2026-03-31$1.88bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure1,972Total assets, Q2 FY2026, at 2026-06-30$1.97bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Current liabilities$m615Current liabilities, Q3 FY2023, at 2023-09-30$615.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0001628908-23-000165.Report this figure674Current liabilities, FY2023, at 2023-12-31$674.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure659Current liabilities, Q1 FY2024, at 2024-03-31$659.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-10, accession 0001628908-24-000053.Report this figure483Current liabilities, Q2 FY2024, at 2024-06-30$483.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0001628908-24-000090.Report this figure524Current liabilities, Q3 FY2024, at 2024-09-30$523.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure716Current liabilities, FY2024, at 2024-12-31$715.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure739Current liabilities, Q1 FY2025, at 2025-03-31$739.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure558Current liabilities, Q2 FY2025, at 2025-06-30$557.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure430Current liabilities, Q3 FY2025, at 2025-09-30$429.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure385Current liabilities, FY2025, at 2025-12-31$385.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure381Current liabilities, Q1 FY2026, at 2026-03-31$381.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure493Current liabilities, Q2 FY2026, at 2026-06-30$492.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Total liabilities$m1,398Total liabilities, Q3 FY2023, at 2023-09-30$1.40bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0001628908-23-000165.Report this figure1,434Total liabilities, FY2023, at 2023-12-31$1.43bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure1,414Total liabilities, Q1 FY2024, at 2024-03-31$1.41bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-10, accession 0001628908-24-000053.Report this figure1,237Total liabilities, Q2 FY2024, at 2024-06-30$1.24bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001628908-24-000090.Report this figure1,276Total liabilities, Q3 FY2024, at 2024-09-30$1.28bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure1,353Total liabilities, FY2024, at 2024-12-31$1.35bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure1,525Total liabilities, Q1 FY2025, at 2025-03-31$1.52bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure1,337Total liabilities, Q2 FY2025, at 2025-06-30$1.34bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure1,611Total liabilities, Q3 FY2025, at 2025-09-30$1.61bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure1,484Total liabilities, FY2025, at 2025-12-31$1.48bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure1,482Total liabilities, Q1 FY2026, at 2026-03-31$1.48bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure1,589Total liabilities, Q2 FY2026, at 2026-06-30$1.59bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Long-term debt$m600Long-term debt, Q3 FY2023, at 2023-09-30$599.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-02, accession 0001628908-23-000165.Report this figure597Long-term debt, FY2023, at 2023-12-31$597.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figure598Long-term debt, Q1 FY2024, at 2024-03-31$597.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-10, accession 0001628908-24-000053.Report this figure599Long-term debt, Q2 FY2024, at 2024-06-30$598.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-09, accession 0001628908-24-000090.Report this figure600Long-term debt, Q3 FY2024, at 2024-09-30$599.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure491Long-term debt, FY2024, at 2024-12-31$490.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure648Long-term debt, Q1 FY2025, at 2025-03-31$647.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure648Long-term debt, Q2 FY2025, at 2025-06-30$648.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure1,055Long-term debt, Q3 FY2025, at 2025-09-30$1.05bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure971Long-term debt, FY2025, at 2025-12-31$970.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure973Long-term debt, Q1 FY2026, at 2026-03-31$973.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure966Long-term debt, Q2 FY2026, at 2026-06-30$966.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$m1.0Short-term borrowings, Q3 FY2023, at 2023-09-30$991.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2023-11-02, accession 0001628908-23-000165.Report this figure0.0Short-term borrowings, FY2023, at 2023-12-31$0. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2025-02-21, accession 0001628908-25-000020.Report this figurenot reportednot reportednot reported171Short-term borrowings, FY2024, at 2024-12-31$171.5m. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure172Short-term borrowings, Q1 FY2025, at 2025-03-31$171.8m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure172Short-term borrowings, Q2 FY2025, at 2025-06-30$172.1m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure5.1Short-term borrowings, Q3 FY2025, at 2025-09-30$5.1m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure0.0Short-term borrowings, FY2025, at 2025-12-31$0. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figurenot reportednot reported
Shareholders' equity$m1,096Shareholders' equity, Q3 FY2023, at 2023-09-30$1.10bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure1,068Shareholders' equity, FY2023, at 2023-12-31$1.07bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001628908-26-000015.Report this figure1,048Shareholders' equity, Q1 FY2024, at 2024-03-31$1.05bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure1,054Shareholders' equity, Q2 FY2024, at 2024-06-30$1.05bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure1,039Shareholders' equity, Q3 FY2024, at 2024-09-30$1.04bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure1,001Shareholders' equity, FY2024, at 2024-12-31$1.00bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure936Shareholders' equity, Q1 FY2025, at 2025-03-31$935.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure896Shareholders' equity, Q2 FY2025, at 2025-06-30$896.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure842Shareholders' equity, Q3 FY2025, at 2025-09-30$842.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure415Shareholders' equity, FY2025, at 2025-12-31$415.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure396Shareholders' equity, Q1 FY2026, at 2026-03-31$396.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure383Shareholders' equity, Q2 FY2026, at 2026-06-30$383.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure

Cash flow

Operating cash flow−$9.3m, Q2 FY2026
Share repurchases$0, Q4 FY2025
Evolent Health, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m60.5Operating cash flow, Q3 FY2023, three months to 2023-09-30$60.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-08, accession 0001628908-24-000114. Derived: 9-month figure less the 6-month figure.Report this figure89.4Operating cash flow, Q4 FY2023, three months to 2023-12-31$89.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure4.9Operating cash flow, Q1 FY2024, three months to 2024-03-31$4.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure21.4Operating cash flow, Q2 FY2024, three months to 2024-06-30$21.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001628908-25-000116. Derived: 6-month figure less the 3-month figure.Report this figure18.7Operating cash flow, Q3 FY2024, three months to 2024-09-30$18.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001628908-25-000133. Derived: 9-month figure less the 6-month figure.Report this figure(26.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$26.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure4.6Operating cash flow, Q1 FY2025, three months to 2025-03-31$4.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(30.3)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$30.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628908-26-000086. Derived: 6-month figure less the 3-month figure.Report this figure15.8Operating cash flow, Q3 FY2025, three months to 2025-09-30$15.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001628908-25-000133. Derived: 9-month figure less the 6-month figure.Report this figure48.8Operating cash flow, Q4 FY2025, three months to 2025-12-31$48.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figure(1.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$984.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure(9.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628908-26-000086. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reported0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reported0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001628908-26-000015. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)112.54m, Q2 FY2026
Evolent Health, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares99.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3099,308,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0001628908-23-000165.Report this figure108Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31107,783,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-10, accession 0001628908-24-000053.Report this figure111Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30111,278,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001628908-24-000090.Report this figure112Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30112,282,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-08, accession 0001628908-24-000114.Report this figure114Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31114,141,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001628908-25-000066.Report this figure115Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30114,688,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001628908-25-000116.Report this figure115Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30114,862,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure115Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31115,315,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure116Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30115,882,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure114Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30114,066,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001628908-25-000133.Report this figure112Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31111,905,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628908-26-000033.Report this figure113Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30112,542,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure

Shares outstanding: 113.06mShares outstanding, period not labelled, at 2026-08-01113,059,335 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001628908-26-000086.Report this figure at Aug 1, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.